Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Tacrolimus ointment is a topical drug (a drug that is applied to the skin) that is used for the treatment of atopic dermatitis (eczema). Atopic dermatitis is a chronic (long-lasting) disease of skin in which the skin becomes inflamed, causing itchiness, redness, swelling, cracking, weeping, crusting, and scaling. The inflammation is caused by activation of the immune system though the reason for the activation is unknown. Tacrolimus ointment suppresses the immune system and the inflammation by inhibiting an enzyme (calcineurin) crucial for the multiplication of T-cells, cells that are required for activation of the immune system. Tacrolimus ointment was approved for the treatment of atopic dermatitis in December 2000.
Market Analysis and Insights: Global Tacrolimus Ointment Market
The global Tacrolimus Ointment market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Tacrolimus Ointment Scope and Market Size
The global Tacrolimus Ointment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tacrolimus Ointment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Ointment 0.1%
Ointment 0.03%
Segment by Application
Adult
Kids
The Tacrolimus Ointment market is analysed and market size information is provided by regions (countries). Segment by Application, the Tacrolimus Ointment market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
LEO Pharma
Sandoz
Glenmark
Zhejiang Wansheng Pharmaceutical
North China Pharmaceutical Company
Humanwell
Sichuan Med-Shine Pharmaceutical
IVA HEALTHCARE
Market Analysis and Insights: Global Tacrolimus Ointment Market
The global Tacrolimus Ointment market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Tacrolimus Ointment Scope and Market Size
The global Tacrolimus Ointment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tacrolimus Ointment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Ointment 0.1%
Ointment 0.03%
Segment by Application
Adult
Kids
The Tacrolimus Ointment market is analysed and market size information is provided by regions (countries). Segment by Application, the Tacrolimus Ointment market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
LEO Pharma
Sandoz
Glenmark
Zhejiang Wansheng Pharmaceutical
North China Pharmaceutical Company
Humanwell
Sichuan Med-Shine Pharmaceutical
IVA HEALTHCARE
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
